Stockscreener 앱 받기
3.98
0.25%
0.010
시간 외 거래:
4.10
0.12
+3.02%
전일 마감가:
$3.97
열려 있는:
$4.01
하루 거래량:
879.74K
Relative Volume:
0.71
시가총액:
$170.35M
수익:
$1.23M
순이익/손실:
$-28.62M
주가수익비율:
-2.5354
EPS:
-1.5698
순현금흐름:
$-14.11M
1주 성능:
+5.85%
1개월 성능:
+21.34%
6개월 성능:
+74.56%
1년 성능:
+19.16%
1일 변동 폭
$3.96
$4.20
1주일 범위
$3.74
$4.20
52주 변동 폭
$1.62
$5.055
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
명칭
Nrx Pharmaceuticals Inc
전화
484-254-6134
주소
1201 ORANGE STREET, WILMINGTON
Compare NRXP vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.98 | 174.63M | 1.23M | -28.62M | -14.11M | -1.5698 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 개시 | H.C. Wainwright | Buy |
| 2025-04-02 | 개시 | BTIG Research | Buy |
Nrx Pharmaceuticals Inc 주식(NRXP)의 최신 뉴스
NRXP Stock Price, Quote & Chart - ChartMill
NRXP News | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals, Inc. (NRXP) Latest Stock News & Headlines - Yahoo Finance
5 Hot Biotech Stocks Under $5 to Buy - Insider Monkey
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per Share - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
Study finds IV ketamine shows higher remission rates than esketamine - Investing.com UK
Study finds IV ketamine shows higher remission rates than esketamine By Investing.com - Investing.com South Africa
NRx Pharmaceuticals announces proposed public stock offering - MSN
NRx Pharmaceuticals notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. - Investing News Network
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. - The Manila Times
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by - GlobeNewswire
Depression study: IV ketamine patients remitted more than nasal esketamine - Stock Titan
NRx Pharmaceuticals Announces Underwriting Agreement and Public Offering of Common Stock - Minichart
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters' Option - Investing News Network
NRx Pharmaceuticals closes $22.3M public offering - Investing.com UK
NRx Pharmaceuticals Announces $20 Million Public Stock Offering - TipRanks
NRx Pharmaceuticals closes $22.3M public offering By Investing.com - Investing.com India
NRX Pharmaceuticals Inc. announced the successful completion of its public offering of common stock, raising a total of $22.3 million. - Bitget
NRX Pharmaceuticals Closes $22.3 Million Stock Offering - marketscreener.com
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option - The Manila Times
NRx Pharmaceuticals Prices $3.50 Stock Offering to Raise ~$18.8 Million; BTIG Leads - TradingView
NRx Pharmaceuticals (NASDAQ: NRXP) closes $22.3M stock sale - Stock Titan
NRx Pharmaceuticals Closes $22.3 Million Public Offering to Support Growth and Development of CNS Therapeutics - Quiver Quantitative
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 - GlobeNewswire
Neuro stocks outpace broader markets as psychedelics, Axsome shine - BioWorld News
NRX Pharmaceuticals Prices Public Offering of 5.7 Million Shares - Moomoo
NRx Pharmaceuticals Shares Drop After $20M Public Offering Prices - Moomoo
NRx Pharmaceuticals Plans Underwritten Public Stock Offering - The Globe and Mail
NRx Pharmaceuticals (NASDAQ: NRXP) sells 5.7M shares at $3.50 - Stock Titan
NRXP: Lucid Capital Manages Successful Offering - GuruFocus
NRx Pharmaceuticals announces pricing of public offering of common stock - MSN
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock - Investing News Network
NRx Pharmaceuticals (NRXP) stock fell 19% after hours on Tuesday: Here's why - MSN
NRx Pharmaceuticals prices $20M public offering at $3.50 By Investing.com - Investing.com Australia
NRx Pharmaceuticals prices $20M public offering at $3.50 - Investing.com
NRx Pharmaceuticals Prices Public Offering of Common Stock to Raise Approximately $20 Million - Quiver Quantitative
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock - Benzinga
Biotech NRx Pharmaceuticals prices $20M stock sale for working capital - Stock Titan
NRx Pharmaceuticals Announces Proposed Public Offering of Common Stock on Nasdaq - Minichart
NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why - Benzinga
Why is NRX Pharmaceuticals stock sliding today? By Investing.com - Investing.com Canada
Nrx Pharmaceuticals Inc (NRXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.60%
0.94%
자본화:
|
볼륨(24시간):